Epstein Secrets

ical Society, of the academies of science in Argentina, Australia, Austria, Brazil, Chile, China, Denmark, Georgia, Hungary, India, Italy, Mexico, New Zealand, Russia, Sweden, Ukraine, the U.K. (the Royal Society), and of the Pontifical Academy of Sciences and the Academy of Sciences for the Developing Wo

ears at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long and varied career. At the Memorial Sloan-Kettering Cancer Center in New York, he was an attending physician in the Department of Medical Oncology and head of the Laboratory of Tumor Biology. He was also Assistan

ged gears in mid-2012 to move away from biomass and to focus on making syngas from natural gas. This is not a new idea: Exx- onMobil built a plant in New Zealand in 1986 to turn natural gas into methanol and then gasoline, but aban- doned its efforts when the price of petroleum dropped dramatically in the mid

ancer How “exceptionalresponders’ ‘arerevolutionizing treatment for the deadly desease BY KAT MCGOWAN UST LIKE EVERY NEW drug the oncologists at Memorial Sloan-Kettering Cancer Center test- ed against bladder cancer in the last 20 years, this one didn’t seem to be doing any good. For- ty-four people in the study were given everolim

ylvania School of Medicine in 1991. Agus completed his residency training at Johns Hopkins Hospital and completed his oncology fellowship training at the Memorial Sloan-Kettering Cancer Center in New York. He spent two years at the National Institutes of Health as a Howard Hughes Medical Institute-NIH Research Scholar. Agus has had a long

ophical Society, of the academies of science in Argentina, Australia, Austria, Brazil, Chile, China, Denmark, Georgia, Hungary, India, Italy, Mexico, New Zealand, Russia, Sweden, Ukraine, the U.K. (the Royal Society), and of the Pontifical Academy of Sciences and the Academy of Sciences for the Developing Worl